United States · FDA National Drug Code directory
Rozlytrek
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-094_b93e1fc0-614a-4e49-a91d-a409fb2db9f0
- Product NDC
- 50242-094
- Form
- CAPSULE
- Composition / generic term
- ENTRECTINIB
- Labeler
- Genentech, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190815
- Source listing expiry
- 20261231
Source-listed ingredients
- ENTRECTINIB — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (50242-094-47) / 90 CAPSULE in 1 BOTTLE · 50242-094-47
- 1 BOTTLE in 1 CARTON (50242-094-90) / 90 CAPSULE in 1 BOTTLE · 50242-094-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →